Clinical Trial Update: Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update compares bevacizumab to ranibizumab for diabetic macular edema, evaluating effectiveness and costs in Phase 2 and Phase 3. Current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avastin (bevacizumab)
• Lucentis (ranibizumab)

Snippet

Sponsor: Prof. dr. R.O. Schlingemann | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: UNKNOWN